Kaspar Zimmermann

Discovery of a Potent and Selective Protein Kinase CK2 Inhibitor by High-Throughput Docking

Eric Vangrevelinghe, Kaspar Zimmermann, Joseph Schoepfer et al. · Journal of Medicinal Chemistry · 2003 · 215 citations

Molecular Docking, Medicinal Chemistry, Drug Target +15

Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 and R-(−)-Deprenyl

Eddy A. Kragten, Isabelle Lalande, Kaspar Zimmermann et al. · Journal of Biological Chemistry · 1998 · 208 citations · Full text

Warum Pentose‐ und nicht Hexose‐Nucleinsäuren??. Teil V. (Purin‐Purin)‐Basenpaarung in der homo‐DNS‐Reihe: Guanin, Isoguanin, 2,6‐Diaminopurin und Xanthin

Katrin Groebke, Jürg Hunziker, W. Hamish Fraser et al. · Helvetica Chimica Acta · 1998 · 91 citations

Nicht Hexose‐nucleinsäuren, Bioorganic Chemistry, Dna Analysis +16

DNA Recognition by Peptide Complexes of Rhodium(III): Example of a Glutamate Switch

Niranjan Y. Sardesai, Kaspar Zimmermann, Jacqueline K. Barton · Journal of the American Chemical Society · 1994 · 78 citations

Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior

Christine E. Gee, Daniel Peterlik, Christoph Neuhäuser et al. · Journal of Biological Chemistry · 2014 · 74 citations · Full text